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The proportion of men and women surviving over 65 years has been steadily increasing over the last century.
In their later years, many of these individuals are afflicted with multiple chronic conditions, placing increasing
pressure on healthcare systems. The accumulation of multiple health problems with advanced age is well
documented, yet the causes are poorly understood. Animal models have long been employed in attempts to
elucidate these complex mechanisms with limited success. Recently, the domestic dog has been proposed as a
promising model of human aging for several reasons. Mean lifespan shows twofold variation across dog breeds.
In addition, dogs closely share the environments of their owners, and substantial veterinary resources are
dedicated to comprehensive diagnosis of conditions in dogs. However, while dogs are therefore useful for
studying multimorbidity, little is known about how aging influences the accumulation of multiple concurrent
disease conditions across dog breeds. The current study examines how age, body weight, and breed contribute to
variation in multimorbidity in over 2,000 companion dogs visiting private veterinary clinics in England.
In common with humans, we find that the number of diagnoses increases significantly with age in dogs. However,
we find no significant weight or breed effects on morbidity number. This surprising result reveals that while
breeds may vary in their average longevity and causes of death, their age-related trajectories of morbidities differ
little, suggesting that age of onset of disease may be the source of variation in lifespan across breeds. Future
studies with increased sample sizes and longitudinal monitoring may help us discern more breed-specific
patterns in morbidity. Overall, the large increase in multimorbidity seen with age in dogs mirrors that seen in
humans and lends even more credence to the value of companion dogs as models for human morbidity and
mortality.
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G
lobal human populations are aging rapidly, with
17% of the population  a predicted 1.6 billion
people  expected to be over the age of 65 by
the year 2050 (1). Among these older individuals, a large
percentage will be afflicted with multiple morbidities.
Incidence of many of these morbidities, including  but
not limited to  diabetes mellitus, arthritis, hypertension,
osteoporosis, neurodegenerative disease, and various
forms of cancer, increases with age. Furthermore, these
diseases often present with each other as multiple (two or
more) morbidities (1,2). However, it is currently unknown
if accumulation of multiple morbidities is a consequence
or a cause of biological aging and shortened longevity. The
significant increase in morbidity count with age suggests
that multimorbidity is a consequence of aging; however,
increases in multiple chronic conditions are associated
with shorter longevity (3), indicating multimorbidity as a
potential cause of biological aging. Close examination of
why certain diseases present together and why others do
not, as well as the trajectories of disease accumulation
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throughout age, can offer critical insights into the biology
of aging. Furthermore, multiple morbidities are often
complex to manage in the clinic and undeniably result in a
heavy burden on social and healthcare infrastructures
currently in place (4,5). For these reasons, the phenomen-
on of age-related multimorbidities has long been recog-
nized as a key area for research in the field of aging (6).
Experimental laboratory animal models are commonly
used to study singular, age-related diseases. However,
studies exploring how different age-related conditions
present and interact with one another are difficult to
perform in experimental models. As such, the genetic and
physiological mechanisms underlying different multimor-
bidity patterns and trends have yet to be adequately
addressed in current animal models. One reason for this
is that most of the popular aging models (flies, yeast,
and worms) are too evolutionarily distant from humans
to model all aspects of individual chronic diseases, let
alone multiple ones. Furthermore, although many murine
models do often present with multiple morbid conditions
(7), aging out large cohorts of genetically diverse mouse
populations is costly, and there are no established systems
known to us for diagnosing, treating, and preventing
chronic conditions in mice. And finally, the environmen-
tal factors that influence aging in laboratory animals are
likely to be wildly different from the environmental effects
that humans experience.
In the current study, we discuss the domestic dog, Canis
lupus familiaris, as a potentially powerful model for
studying the age-related accumulation of morbid condi-
tions. Dogs offer a host of advantages for studying disease,
perhaps the most pronounced of which is their unique
breed-based population structure. The domestic dog, which
is the most phenotypically diverse mammal species on earth
(8), exhibits high phenotypic heterogeneity among breeds,
in addition to phenotypic and genetic homogeneity within
breeds (9). Moreover, breeds of dogs tend to present with
distinct patterns of diseases and causes of death (10). Dogs
and humans also share many diseases that present in old
age, and the quality of medical care for dogs is second only
to that for humans. Furthermore, companion dogs share
our environment and its associated disease risk factors in
a way that can never be replicated in a laboratory. These
facts make the companion dog an exciting model in which
to study complex diseases.
Here, we present multimorbidity patterns across an ex-
tensive database of electronic veterinary records in dogs
with the aims of 1) understanding how multimorbidity
trends vary with age, body weight, and breed within a
population, and 2) highlighting the translational poten-
tial of the dog model in future studies of multimorbidity
and aging. We are interested in body weight because of
its large influence on lifespan  small breeds tend to live
longer than larger breeds (11,12). Thus, we hypothesize
that both dog body weight and age will have significant
effects on multimorbidity patterns, specifically that the
number of morbidities will increase with increasing
observed age and body weight of dogs presenting in an
extensive database of electronic medical records from
veterinary clinics in the UK.
Methods
Data
Multimorbidity data on a large cohort of dogs were
acquired from the VetCompass database of the Royal
Veterinary College in the United Kingdom (13). Data were
included from dogs attending primary practice veterinary
clinics in England over the course of 3.5 years, from 2009
to 2013. Some dogs visited their veterinarians several
times over the period, whereas others had a single visit.
All defining symptoms/diagnoses recorded for each dog
during the study period were extracted, and we considered
each defining symptom/diagnosis to be a morbidity for
that dog. Full details of the methods used for developing
the data set used for this study have been previously
published (13). We removed descriptors or procedures that
were not related to the health of the animal or were
determined by one of the authors (KEC) to be too vague
(e.g. ‘puppy vet check’, ‘ID chip insertion’, and ‘nail clip’).
The total number of diagnoses for each dog was summed
and treated as the morbidity score for each dog. Thus, all
included diagnoses were weighted equally. While some
dogs had more than one included veterinary record across
the time period of data collection, only a single age was
recorded for each dog.
This age was assigned by subtracting the dog’s birthdate
from the last day it visited the veterinary clinic. Dogs
under 1 year of age were removed from the analysis due to
their constantly changing body weights. In addition, only
those dogs with both body weight and age data recorded
were included in the analysis. Dogs were separated into
small (B10 kg), medium (1020 kg), or large (20 kg)
body weight classes. Weight class cut-offs were based
on a modified version of cut-offs previously assigned by a
veterinarian in another study (14). We then chose those
breeds with the largest sample sizes in the database (i.e.
breeds represented by at least 50 individuals), and grouped
them by breed standard into their respective weight
classes: small (Jack Russell Terrier, West Highland White
Terrier, Shih-Tzu, and Cavalier King Charles Spaniel),
medium (Border Collie, Staffordshire Bull Terrier, Cocker
Spaniel, and English Springer Spaniel), and large (Labrador
Retriever, Golden Retriever, and Rottweiler). Breeds were
grouped into weight classes based on American Kennel
Club average weights (15). Mixed breeds, which represented
the largest sized sample population, were excluded from this
analysis, allowing us to determine the effects of genetic
homogeneity on multimorbidity number. Ethical appro-
val for the study was granted by the Royal Veterinary
Kelly Jin et al.
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College Ethics and Welfare Committee (reference number
2015/1369).
Statistical models
Due to the discrete and over-dispersed (i.e. non-Gaussian)
nature of the morbidity data, we first used a generalized
linear model (GLM) with a negative-binomial distribu-
tion to discover the effects of age, body weight, and their
interaction on the morbidity scores, treating all factors as
fixed effects. Next, we looked among individual breeds
within each different weight classes to see whether there
was significant breed variation for age-related changes in
multimorbidity within similar-sized dogs. Similar to our
weight analysis, we ran a GLM with a negative-binomial
distribution for each individual weight class for the effects
of breed, age, and their interaction on morbidity score.
All statistical analyses were completed in the program
R (16). We used a model selection approach to identify the
best distribution of the data based on Akaike’s informa-
tion criterion (AIC) (17). For each candidate model, an
AIC was computed using the R package fitdistrplus (18),
and the model with the lowest AIC was selected as the
best-supported distribution. Regressions were performed
using the R package MASS (19).
Results
Distribution of multiple morbidities
The original database consisted of 3,225 adult dogs (aged
over 1 year at their final record), of which 2,586 (80.2%)
had both body weight and age data, andwere thus included
in the analysis. The distribution of morbidity scores across
all dogs in the data set more closely follow a negative-
binomial distribution rather than a Poisson distribution
(AICnegbinomBAICpois; Fig. 1a). Morbidity scores across
dogs separated by weight class follow very similar dis-
tributions (Fig. 1ce; MannWhitney test results: p0.05
for all pairwise comparisons), suggesting that there
are very few differences between differently sized dogs in
terms of the number of morbidities accumulated over the
lifetime.
The distributions of the ages of the dogs at the time
of their visits are shown in Table 1 and Fig. 1b and fh.
In contrast to the size class-specific morbidity score dis-
tributions, the shape of age distributions varies noticeably
between weight classes. Among small dogs, the greatest
number of dogs seen by the veterinarian were 1 year old,
whereas in medium and large dogs, that age increases
(3 and 5 years old, respectively).
Age, but not body weight or breed, affects
multiple morbidities
To determine whether age and/or body weight are signi-
ficantly associated with multimorbidity score, we ran
a GLM of morbidity score as a function of age, weight,
and their interaction. As expected, there was a highly
significant positive effect of age on number of diagnoses
(p2.34E-12, Table 2 and Fig. 2). This trend represents a
highly significant effect of age on morbidity score across
all dogs. However, failing to support the initial study
hypothesis, no significant association was detected be-
tween body weight (p0.777) and age-by-weight inter-
actions (p0.278) on multimorbidity score.
We then broke down the weight classes into individual
breeds (Fig. 3). Our breed-based analysis surveyed 12
breeds comprising 1,278 dogs. In medium and large breeds,
age was significantly associated with morbidity score
(pB7.31E-04, Table 3), consistent with trends observed
in the entire data set (Table 2). Specific breeds did not
vary with respect to morbidity score in any weight class.
Interestingly, no significant effects of breed, age, or their
interaction were found on morbidity score in small dogs.
Discussion
We began our investigation by exploring the distribution
of morbidity scores across all dogs in the VetCompass
data set. We found that all morbidity scores follow a
non-Poisson distribution (Fig. 1a and ce). The Poisson
distribution is used to describe events that are randomly
scattered over space or time. Departures from Poisson,
therefore, are often interpreted as departures from ran-
domness and neutrality (20). Thus, much like how
departures from HardyWeinberg equilibrium suggest
the presence of forces acting upon genetic variation in a
population (21), the deviations from Poisson in our data
imply that accumulation of multimorbid conditions is not
a random process and that other forces may be signifi-
cantly influencing multimorbidity rates in dogs. At pre-
sent, we are unable to identify what these external forces
may be, but the question is an exciting one, that further
underscores the research potential of the canine model for
understanding multimorbidity.
We also found that the shapes of the morbidity dis-
tributions did not differ substantially between body weight
classes of dog. This observation is intriguing, as it is well
documented that large dogs have shorter lifespans than
small dogs (10). Therefore, one might expect that larger
breeds may have a different distribution of disease accu-
mulation than smaller breeds. However, this does not
appear to be the case, as all size classes of dogs have
similar morbidity score distributions.
Of many potential factors that might influence this
unexpected observation, one is the distribution of ages of
presenting dogs. Despite similar distributions of morbi-
dity scores, we discovered differences among body weight
groups of dogs in the most frequent age of presentation
to the veterinary practices (Fig. 1fh). This interesting
observation indicates that there may be external factors
influencing the age at which dogs are most likely to
present to the clinic, and those factors may vary based on
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size and/or breed of the animal. We need more data on
the timing of disease manifestation between different
size classes, and by definition, different breeds of dogs.
In addition to the breed-specific differences in the age at
onset of different diseases, extrinsic forces may also affect
these patterns. For example, recent increases in popularity
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Fig. 1. Morbidity scores and ages of dogs in the VetCompass data set. Shown are distributions of (a) morbidity scores and (b) age of
dog at veterinary visit across all dogs in the data sets; (ce) morbidity score and (fh) age distributions of dogs are also visualized by
body weight class as labeled. Total number of animals in each weight class is as follows: nsmall766, nmedium692, nlarge1,128, and
ntotal2,586.
Table 1. Summary statistics of distributions of ages (in years) of dogs in the VetCompass data
Mean Minimum 1st quartile Median 3rd quartile Max Count
Small dogs 6.52 1.01 2.87 5.45 9.6 18.48 766
Medium dogs 6.95 1.01 3.36 6.11 10.16 18.74 692
Large dogs 7.07 1 3.84 6.53 9.95 17.52 1,128
All dogs 6.87 1 3.39 6.08 9.92 18.74 2,586
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of certain small dog breeds [e.g. rising ownership of Pugs
in England (22)] would result in an observed distri-
bution skewed towards younger small dogs. In a growing
population, younger dogs would make up a larger pro-
portion of the sample population. Given the recent
growth in this small, relatively long-lived breed, this
demographic phenomenon could skew morbidity counts
towards lower levels.
We found that across all dogs, multimorbidities increase
significantly with age, but not with size (Table 2 and Fig. 2).
Overall, this trend holds within breeds of different size
classes as well. We know that frequencies of specific diag-
noses differ among size classes of dogs (10,13). However,
within our data set, the total number of morbidities for
each dog is dependent almost exclusively on age with no
detectable effect of weight or breed. Different breeds are
known to experience different morbidities, as well as to
have different causes of death (10,23). In this light, we
would have expected to find that certain breeds were more
prone to multiple morbidities, but our study failed to
identify this association. This suggests that there is little
effect of breed on the overall number of multiple morbid-
ities, only the types of morbidities. However, replicate and
controlled studies are needed to test this hypothesis more
directly.
Additionally, the choice to weight each diagnosis
equally may have allowed the morbidity scores to appear
the same across breeds, while the actual burden of disease
comprising each score differed. Existing morbidity in-
dices for humans often weigh specific measures by their
potential effect on overall function (24,25). Future clini-
cal studies on aging in dogs could benefit greatly from
developing such weighted measures.
Our breed-based analysis showed similar patterns as
seen in the data set overall, with one exception. Small dog
breeds failed to show a significant effect of age on mor-
bidity score, suggesting that compared with larger dogs,
small dogs may differ physiologically in a way that atte-
nuates the effect of age on multimorbidity. This hypoth-
esis is consistent with the observation that smaller dog
breeds tend to live longer than larger breeds, as well
as with the idea that smaller dogs may be aging more
slowly (11,12).
Overall, our results highlight a novel and valuable
application of the companion dog as a model for age-related
multimorbidities in humans. We believe the key
to its value, in part, lies in the dog’s ability to model
non-biological variables in addition to biological ones.
Biological variables, including sex, neutering, body weight,
and age, are important variables that can contribute to the
development of chronic disease, but they are not the only
important variables. Non-biological factors include, but are
not limited to, environmental, behavioral, social, and eco-
nomic components and have large and complex effects on
both canine and human health. For example, several previous
papers employing the VetCompass database have highlighted
dramatic financial and social effects from pet insurance
on disease diagnosis and survival rates. Compared with
non-insured dogs, insured dogs are four times more
likely to be diagnosed with hyper-adrenocorticism (26),
Table 2. Results of linear model on age, weight, and age-by-
weight interaction
Variable Estimate Std. error z Pr(jzj)
Intercept 0.463 6.12E-02 7.575 3.59E-14
Age 5.15E-02 7.35E-03 7.013 2.34E-12
Weight 7.87E-04 2.78E-03 0.283 0.777
Age*weight 3.67E-04 3.39E-04 1.084 0.278
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Fig. 2. Age-related changes in morbidity scores for dogs by body weight class. Error bars indicate 91 standard error. Due to small
sample size, all dogs within a weight class with age ]15 years were grouped together for visualization purposes.
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cranial cruciate disease (27), and mast cell tumor (28). Non-
insured diabetic dogs have 1.7 times the hazard of death
compared with insured dogs (29). Consequently, we believe
that with the increase in available data, and improvements in
data science methods, the scientific and medical research
community can now incorporate these non-biological factors
when investigating complex biological processes such as
aging. Given that dogs and humans share many environ-
mental risk factors such as the same air and water pollutants,
similar levels of exercise by exercising together, and similar
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Fig. 3. Age-related changes in morbidity scores for dogs by breed. Breeds are grouped by (a) small, (b) medium, and (c) large weight
class. Error bars indicate 91 standard error. Due to small sample size, all dogs within a breed with age ]15 years were grouped
together for visualization purposes.
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potential economic constraints, such as access to medical
care, the potential of the dog both as a sentinel (30) and
translational model is high.
Caveats
While this is the largest multimorbidity analysis in the dog
to date, our analysis was not without its limitations. First,
our sample size of just over 2,500 dogs is still relatively
small, especially once divided by breed. To better under-
stand age-related changes in multimorbidities, we need
studies with many more dogs at various ages in each
breed, and a better understanding of the distribution of
the complete at-risk population in terms of age, size, and
breed. Furthermore, the relatively small sample size of this
data set did not allow us to look at the effects of sex and
sterilization status, the latter of which significantly affects
disease risk and mortality (14,31).
Second, as described above, we treated every diagnosis
the dog had been given with equal weight, other than
those removed for vagueness and/or irrelevance as de-
scribed in the Methods section. As such, some morbidities
may only have minor effects on the physiology and health
of the dog. Many studies in humans have used similarly
unweighted disease counts as measures of multimorbidity
(25), though inclusion criteria for specific diseases can
vary. Our current unweighted approach may have acted to
limit our ability to detect the true differences of accumu-
lated morbidity between small and large dogs. That is to
say, while the distributions of multiple morbidities we
present are similar in small and large dogs (Fig. 1c and e),
conditions in large dogs could be more detrimental to
overall health than those in small dogs.
Third, owners may choose to euthanize dogs before they
develop their ‘maximum’ morbidity levels. The original
study from which these data were derived reported that
88.9% of the recorded deaths were by euthanasia (13). This
could have a strong confounding effect on certain breeds;
since we know that diverse breeds differ in disease profile,
some of the more debilitating and painful diseases that
lead to earlier euthanasia might be over-represented
among certain breeds (10,32).
Fourth, the nature of this data set does not allow us to
know if these diagnoses were chronic within each dog or
were only present at one specific time point. Many human
studies focus specifically on multiple chronic conditions (2),
Table 3. Results of analysis of variance for breed and age within different weight classes
Variable Estimate Std. error t p
Small breeds
Intercept 0.762 0.217 3.504 4.58E-04
Age 8.96E-05 6.54E-05 1.369 0.171
Cavalier King Charles Spaniel 0.182 0.297 0.613 0.540
Jack Russell 0.447 0.257 1.738 0.082
West Highland White Terrier 0.510 0.319 1.599 0.110
Yorkshire Terrier 0.321 0.285 1.125 0.261
Age*Cavalier King Charles Spaniel 4.80E-05 9.64E-05 0.498 0.618
Age*Jack Russell 7.41E-05 7.65E-05 0.969 0.333
Age*West Highland White Terrier 1.45E-04 9.33E-05 1.563 0.118
Age*Yorkshire Terrier 4.96E-05 8.63E-05 0.574 0.566
Medium breeds
Intercept 0.302 0.219 1.379 0.168
Age 2.02E-04 6.00E-05 3.378 7.31E-04
Cocker Spaniel 0.279 0.280 0.996 0.319
English Springer Spaniel 0.303 0.283 1.071 0.284
Staffordshire Bull Terrier 0.184 0.252 0.732 0.464
Age*Cocker Spaniel 4.80E-05 8.62E-05 0.557 0.578
Age*English Springer Spaniel 4.82E-07 8.16E-05 0.006 0.995
Age*Staffordshire Bull Terrier 9.93E-05 7.59E-05 1.307 0.191
Large breeds
Intercept 2.53E-02 0.280 0.090 0.928
Age 3.02E-04 8.14E-05 3.716 2.02E-04
Labrador Retriever 0.507 0.303 1.670 0.095
German Shepherd 4.52E-02 0.344 0.131 0.895
Age*Labrador Retriever 1.65E-04 9.00E-05 1.841 0.066
Age*German Shepherd 5.32E-06 1.06E-04 0.050 0.960
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which we were not able to ascertain from this population.
An ideal canine study of chronic multimorbidities
would follow dogs throughout life to discover the degree
to which different conditions persist throughout the life-
span of the dog.
Finally, other unexamined factors likely affect the
observed distribution (which might differ from the true
distribution) of morbidities. For example, the probability
that an owner brings a dog to clinic might be a function
of the animal’s multimorbidity score, leading to ascer-
tainment bias. Higher multimorbid individuals may be
more likely to be brought to the clinic; additionally, these
animals may be shorter-lived overall, leading to a right
truncation of the data due to high-morbidity individuals
existing in that state for a shorter time period compared
with those individuals with fewer morbidities. Further-
more, individual morbidity scores can move backwards in
the real world with the cure of some morbidities due to
pharmacological interventions or lifestyle changes, which
would not be reflected in our cross-sectional data as such.
Hidden variables such as these can only be revealed and
accounted for with long-term longitudinal studies  an
approach that will be key to future advancement in our
understanding of the causes and consequences of aging
and age-related disease.
Conclusions
Here, we have presented the largest multimorbidity analy-
sis in the companion dog to date. We find little variation in
morbidity scores across dogs of varying body-weight
groups despite previously published dramatic variation
in causes and ages of death across weight classes and
individual breeds (10,33). Furthermore, most of the
variation in morbidity score patterns can be explained
by age rather than the body size or breed of the dog,
suggesting that age is a major, if not the most influential,
risk factor for accumulation of disease in dogs, as it is in
humans. Although much more investigation is needed to
identify mechanisms of multimorbidity, this early study
has revealed interesting insights into the architecture of
morbidity across dog breeds. This study further shows that
the companion dog can be an excellent model for studying
disease variation and age-related decline in health.
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